PPH Legal Blog

In early July, GeneraMedix was approved by the FDA for its Epoprostenol for injection 1.5mg drug. GeneraMedix’s Epoprostenol for injection 1.5mg is meant to be a long-term intravenous treatment for primary pulmonary hypertension (PPH).
PHH is caused by the thinning or narrowing of the blood vessels that supply the lungs. If left untreated, an individual’s blood […]

[Read more →]

After eight long weeks, the trial of Gallion and Cunningham ended in a mistrial due to a deadlocked jury. Their partner, Melbourne Mills, was acquitted before the jury became stuck on the charges against the former two. All three attorneys were accused of stealing $65 million dollars from the $200 million dollar lawsuit filed by […]

[Read more →]

The Fen-phen trial, in which three attorneys who represented Fen-phen users are on trial for looting a $200 million settlement, remains undecided after its second day of jury deliberation.  The trio of lawyers has been accused of conspiracy to commit wire fraud.  If found guilty, each defendant faces up to 20 years in prison and […]

[Read more →]

After taking a diet drug, Fen-phen, for a short period of time, long ago, Carolyn W. forgot all about it.  As a flight attendant, inactivity on long plane rides occurred frequently.  Weight gain was a side effect of the job and Carolyn heard about a simple solution from a coworker.  After taking the drugs for […]

[Read more →]

In the recent trial of three prominent lawyers accused of taking $65 million from their clients’ lawsuit against makers of the diet drug Fen-phen, the defendant Melbourne Mills Jr. was recently hospitalized, delaying the trial.  In addition to the financial theft from their clients’ $200 million settlement, each of the lawyers is also accused of […]

[Read more →]